These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25907632)

  • 1. The KM-parkin-DB: A Sub-set MutationView Database Specialized for PARK2 (PARKIN) Variants.
    Mitsuyama S; Ohtsubo M; Minoshima S; Shimizu N
    Hum Mutat; 2015 Aug; 36(8):E2430-40. PubMed ID: 25907632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of autosomal recessive juvenile Parkinson's disease mutations on the structure and interactions of the parkin ubiquitin-like domain.
    Safadi SS; Barber KR; Shaw GS
    Biochemistry; 2011 Apr; 50(13):2603-10. PubMed ID: 21348451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.
    Hristova VA; Beasley SA; Rylett RJ; Shaw GS
    J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of compound heterozygous deletions in the parkin gene of fibroblasts in patients with autosomal recessive hereditary parkinsonism (PARK2).
    Nakaso K; Adachi Y; Yasui K; Sakuma K; Nakashima K
    Neurosci Lett; 2006 May; 400(1-2):44-7. PubMed ID: 16517073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
    Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
    J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
    Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
    Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive computational study on pathogenic mis-sense mutations spanning the RING2 and REP domains of Parkin protein.
    Biswas R; Bagchi A
    Gene; 2017 Apr; 610():49-58. PubMed ID: 28189762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the parkin gene in Russian families with autosomal recessive juvenile parkinsonism.
    Illarioshkin SN; Periquet M; Rawal N; Lücking CB; Zagorovskaya TB; Slominsky PA; Miloserdova OV; Markova ED; Limborska SA; Ivanova-Smolenskaya IA; Brice A
    Mov Disord; 2003 Aug; 18(8):914-9. PubMed ID: 12889082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of phospho-ubiquitin-induced PARKIN activation.
    Wauer T; Simicek M; Schubert A; Komander D
    Nature; 2015 Aug; 524(7565):370-4. PubMed ID: 26161729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.
    Fiesel FC; Caulfield TR; Moussaud-Lamodière EL; Ogaki K; Dourado DF; Flores SC; Ross OA; Springer W
    Hum Mutat; 2015 Aug; 36(8):774-86. PubMed ID: 25939424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARKIN as a pathogenic gene for autosomal recessive juvenile parkinsonism.
    Shimizu N; Asakawa S; Minoshima S; Kitada T; Hattori N; Matsumine H; Yokochi M; Yamamura Y; Mizuno Y
    J Neural Transm Suppl; 2000; (58):19-30. PubMed ID: 11128608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational Impact on "in-Between-Ring" (IBR) Domain of PARKIN on Protein Stability and Function.
    Biswas S; Bagchi A
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1603-1616. PubMed ID: 33471285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism.
    Lesage S; Magali P; Lohmann E; Lacomblez L; Teive H; Janin S; Cousin PY; Dürr A; Brice A;
    Hum Mutat; 2007 Jan; 28(1):27-32. PubMed ID: 17068781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
    Biswas S; Roy R; Biswas R; Bagchi A
    Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India.
    Vinish M; Prabhakar S; Khullar M; Verma I; Anand A
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):166-70. PubMed ID: 19734163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3eta is a novel regulator of parkin ubiquitin ligase.
    Sato S; Chiba T; Sakata E; Kato K; Mizuno Y; Hattori N; Tanaka K
    EMBO J; 2006 Jan; 25(1):211-21. PubMed ID: 16096643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of the Parkin gene in a Persian family: clinical progression over a 40-year period.
    Clarimon J; Johnson J; Djaldetti R; Hernandez D; Hattori N; Sroka H; Barhom Y; Singleton A
    Mov Disord; 2005 Jul; 20(7):887-90. PubMed ID: 15852366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine Parkin: molecular cloning of PARK2 cDNA, expression analysis, and identification of a splicing variant.
    Bjerre D; Madsen LB; Bendixen C; Larsen K
    Biochem Biophys Res Commun; 2006 Sep; 347(3):803-13. PubMed ID: 16844087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease.
    Beasley SA; Hristova VA; Shaw GS
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3095-100. PubMed ID: 17360614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.